PetVivo is a veterinary biotech and biomedical device company dedicated to improving the lives of companion animals, such as dogs and horses, suffering from arthritis and other ailments. They specialize in translating or adapting human biotech and medical technology into innovative products for the veterinary market. With a focus on biomatrix materials, PetVivo has developed a range of proprietary thermoplastic protein-based biomaterials that mimic the body's tissue.

Having received significant recognition, PetVivo has been awarded multiple grants, including $5. 5 million from the National Institutes of Health. Their dedication to research and development has resulted in a portfolio of 19 patents and 8 pending patent applications, protecting their biomaterials, production processes, and methods of use.

PetVivo's flagship product, Spryng™ with OsteoCushion™ Technology, represents the first commercialization of their biomatrix technology. This veterinary medical device is designed to manage lameness issues, joint pain, and osteoarthritis in animals. Backed by scientific excellence and a passionate leadership team, PetVivo is poised to continue innovating in the field of veterinary medicine.

Note: The data provided in the input does not include specific details about the products and services PetVivo offers, hence the description is based on the information extracted